CHDH: Key Protein in Fetal Development and Pregnancy Outcomes

Target Name: CHDH

NCBI ID: G55349

CHDH

CHDH: Key Protein in Fetal Development and Pregnancy Outcomes

CHDH (CHDH_HUMAN), also known as human chorionic dipeptide (hCG), is a glycoprotein that is produced by the placenta during pregnancy. It is a key protein in the development and maintenance of the human fetus, and it has been linked to a number of important biological processes, including fetal growth, development, and pregnancy outcomes.

CHDH is expressed in a variety of tissues throughout the body, including the placenta, liver, kidneys, and heart. It is typically synthesized in the placenta at a level of around 100 ng/mL, and it is secreted into the bloodstream at a rate of around 10 ng/mL per minute.

One of the key functions of CHDH is its role in fetal growth and development. CHDH has been shown to play a critical role in the formation and maintenance of the neural tube, which will eventually become the brain and spinal cord. During pregnancy, CHDH is expressed in high levels in the placenta and has been shown to stimulate the growth and development of neural tube cells.

Another important function of CHDH is its role in pregnancy outcomes. Studies have shown that levels of CHDH in the placenta are significantly higher in pregnant women who have a history of preterm labor compared to those who do not have such a history. This suggests that CHDH may be a useful biomarker for the prediction of preterm labor and for the evaluation of the effectiveness of different treatments for preterm labor.

In addition to its role in fetal growth and development, CHDH has also been shown to have a number of potential therapeutic applications. For example, CHDH has been shown to be effective in preventing the formation of blood clots, which can be a serious risk for both pregnant women and their babies. In addition, CHDh has been shown to have anti-inflammatory effects, which may make it a useful treatment for a variety of inflammatory disorders.

Overall, CHDH is a protein that has important roles in the development and maintenance of the human fetus, and it is worth further research as a potential drug target or biomarker.

Protein Name: Choline Dehydrogenase

The "CHDH Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHDH comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets